Targeted therapies reshape CLL treatment, shifting focus from age to comorbidities, and patient preferences.
2025 Pan Pacific Leukemia Conference
Review updates and insights focused on chronic lymphocytic leukemia from the 2025 Pan Pacific Leukemia Conference.
Targeted therapies reshape CLL care as experts weigh time-limited vs indefinite frontline treatment strategies.
Dr. Vose outlined the biggest takeaways from the CLL session at the 2025 Pan Pacific Leukemia Conference.
Novel agents are reshaping treatment for double-refractory CLL, offering new hope for this tough-to-treat disease.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.